National Health Investors, Inc.
As of Oct 15, 2026 close
- Market cap
- $3.18B
- P/E (TTM)
- 19.10
- Forward P/E
- 16.19
- Dividend yield
- 5.63%
- 52-week range
- $63.51$91.38
- Volume (live)
- -
- Avg. volume (3M)
- 376.07K
National Health Investors (NHI) Stock Price & Financial Analysis
National Health Investors Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $65.64 - $67.18 |
|---|---|
| 52-Week High | $91.38 |
| 52-Week Low | $63.51 |
| Open | $66.49 |
| Volume (last close) | 217.19K |
| Average Volume (3M) | 376.07K |
| Revenue (TTM) | 432.84M |
|---|---|
| Net Income (TTM) | 166.72M |
| Free Cash Flow (TTM) | 235.71M |
| EPS (TTM) | $3.48 |
| Profit Margin | 38.52% |
| Operating Margin | 45.46% |
| Return on Equity (ROE) | 10.61% |
| Debt to Equity | 0.82 |
| Annual Dividend | $3.70 |
|---|---|
| Dividend Yield | 5.63% |
| Payout Ratio | 106.37% |
| Last Dividend Ex-Date | Sep 30, 2026 |
| Market Cap | 3.18B |
|---|---|
| Shares Outstanding | 48.50M |
| P/E Ratio (TTM) | 19.10 |
| Forward P/E | 16.19 |
| Price to Sales (P/S) | 7.36 |
| Price to Book (P/B) | 2.03 |
| EV/EBITDA | 14.20 |
| 50-Day MA | $69.78 |
|---|---|
| 200-Day MA | $77.05 |
| 1-Year Change | −10.68% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
National Health Investors at a Glance
As of the Oct 15, 2026 close, National Health Investors (NHI) has a market capitalization of $3.18B. The stock trades at 19.1× trailing earnings, 16.2× forward earnings and 7.4× sales. Over the trailing twelve months it earned $166.72M on revenue of $432.84M (a 38.5% profit margin) and generated $235.71M of free cash flow. Revenue grew 23.9% year over year.
As of its latest reported balance sheet, it holds $30.39M in cash and securities against $1.28B of debt, a net debt position of $1.25B.
National Health Investors pays a quarterly dividend totaling $3.70 per share a year, a 5.63% yield at the Oct 15, 2026 close, with a 106% payout ratio and 1 consecutive year of dividend increases.
The share price is down 10.7% over the past year. At $65.67 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $63.51 to $91.38, below its 200-day moving average of $77.05.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $82.17, 25.1% above the Oct 15, 2026 close.
Frequently Asked Questions About National Health Investors
What is the current stock price for NHI?
As of the Oct 15, 2026 close, NHI stock trades at $65.67. The 52-week range is $63.51–$91.38, with a day range of $65.64–$67.18.
What is the P/E ratio for NHI?
As of the Oct 15, 2026 close, National Health Investors's trailing twelve-month (TTM) P/E ratio is 19.1, meaning investors pay $19.1 for every $1 of annual earnings. The forward P/E is 16.2, reflecting analyst expectations for future earnings. National Health Investors operates in the Real Estate sector.
Does NHI pay dividends?
Yes, National Health Investors pays a 5.63% annual dividend yield as of the Oct 15, 2026 close ($3.70 per share a year). The trailing twelve-month payout ratio is 106.4%. The most recent ex-dividend date was September 30, 2026.
What do analysts recommend for NHI?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for NHI is Buy. The average 12-month price target is $82.17, a 25.1% upside from the Oct 15, 2026 close of $65.67.
What is the market cap of NHI?
As of the Oct 15, 2026 close, National Health Investors's market capitalization is $3.18B, classifying it as a mid-cap company. National Health Investors operates in the Real Estate sector within the REIT - Healthcare Facilities industry.